Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
CALL
Takeda Pharmaceutical
TAK
$55.8B
| $5.48M | ﹤0.01% |
305,424
+40,188
| +15% | +$721K |
|
1302
Clearway Energy Class C
CWEN
$7.08B
| $5.46M | ﹤0.01% |
236,961
-7,835
| -3% | -$166K |
|
|
HCCH
1303
DELISTED
HL Acquisitions Corp. Ordinary Shares
HCCH
| $5.46M | ﹤0.01% |
+448,442
| New | +$4.94M |
|
1304
BJs Wholesale Club
BJ
$12B
| $5.46M | ﹤0.01% |
146,385
+47,326
| +48% | +$1.45M |
|
1305
Semtech
SMTC
$12.2B
| $5.44M | ﹤0.01% |
104,154
+16,708
| +19% | +$782K |
|
1306
CALL
TJX Companies
TJX
$172B
| $5.43M | ﹤0.01% |
107,500
-27,400
| -20% | -$1.38M |
|
|
1307
Takeda Pharmaceutical
TAK
$55.8B
| $5.43M | ﹤0.01% |
303,091
-35,864
| -11% | -$644K |
|
|
SPLK
1308
PUT
DELISTED
Splunk Inc
SPLK
| $5.42M | ﹤0.01% |
27,300
-44,400
| -62% | -$7.02M |
|
1309
CALL
APA Corp
APA
$14.2B
| $5.42M | ﹤0.01% |
401,100
-560,700
| -58% | -$6.4M |
|
1310
PUT
Constellation Brands
STZ
$22.9B
| $5.41M | ﹤0.01% |
30,900
-54,400
| -64% | -$9.06M |
|
|
USX
1311
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $5.41M | ﹤0.01% |
901,046
-102,283
| -10% | -$467K |
|
1312
LXP Industrial Trust
LXP
$3.58B
| $5.4M | ﹤0.01% |
102,299
+56,806
| +125% | +$2.86M |
|
|
BAL
1313
DELISTED
iPath Series B Bloomberg Cotton Subindex Total ReturnSM ETN
BAL
| $5.39M | ﹤0.01% |
149,000
| – | – |
|
1314
Kinross Gold
KGC
$32.3B
| $5.39M | ﹤0.01% |
746,495
-751,639
| -50% | -$4.88M |
|
1315
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $5.38M | ﹤0.01% |
268,803
-682,933
| -72% | -$12.4M |
|
1316
Interactive Brokers
IBKR
$40.7B
| $5.38M | ﹤0.01% |
515,328
+80,996
| +19% | +$847K |
|
1317
Post Holdings
POST
$3.56B
| $5.38M | ﹤0.01% |
93,761
+26,729
| +40% | +$1.56M |
|
|
SFIX
1318
Stitch Fix
SFIX
$499M
| $5.37M | ﹤0.01% |
215,281
-11,003
| -5% | -$217K |
|
1319
Pinnacle West Capital
PNW
$12.1B
| $5.37M | ﹤0.01% |
73,273
-27,575
| -27% | -$2.08M |
|
1320
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
| $5.36M | ﹤0.01% |
8,600
-20,800
| -71% | -$11.8M |
|
|
PENG
1321
Penguin Solutions Inc
PENG
$2.94B
| $5.33M | ﹤0.01% |
392,108
+79,000
| +25% | +$1.01M |
|
1322
CareDx
CDNA
$2.44B
| $5.32M | ﹤0.01% |
150,099
+40,700
| +37% | +$1.16M |
|
1323
Match Group
MTCH
$8.45B
| $5.32M | ﹤0.01% |
49,680
+21,058
| +74% | +$1.76M |
|
1324
Neurocrine Biosciences
NBIX
$16.5B
| $5.31M | ﹤0.01% |
43,548
+12,558
| +41% | +$1.39M |
|
1325
LKQ Corp
LKQ
$6.25B
| $5.31M | ﹤0.01% |
202,695
-6,957
| -3% | -$171K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.